Noninvasive Fetal Screening Effectively Detects Abnormalities
Massachusetts General Hospital
Noninvasive method has the potential to survey the entire fetal exome without the need for amniocentesis
An international research consortium has tested a rapid new analytical tool that needs just a blood sample from a fingerprick
Liquid biopsies help extract and screen circulating tumor DNA for cancer-causing anomalies well in advance
Novel blood test detects the highly specific ORF1p biomarker found in multiple cancers
The chip generates results in less than 3.5 hours and helps treat bloodstream infections and sepsis quickly and accurately